Clinical Study

Pericardial Fat Relates to Disturbances of Glucose Metabolism in Women with the Polycystic Ovary Syndrome, but Not in Healthy Control Subjects

Table 1

Basic characteristics of the study population.

PCOS total ()PCOS-NIH ()PCOS-ROT ()Controls () value

Age (years)25 (21–30)25 (21–28)24 (22–32)23 (23–25)0.475
BMI (kg/m2)24 (22–30)25 (23–30)23 (21–30)21 (20–24)0.005
Waist (cm)84 (74–93)88 (80–96)75 (69–84)78 (75–85)0.003
RRsys (mmHg)114 (105–120)113 (107–121)115 (104–122)116 (111–126)0.487
RRdia (mmHg)72 (65–79)72 (66–79)70 (63–78)73 (63–76)0.739
HF (beats per minute)73 (64–80)74 (66–85)72 (64–80)74 (63–77)0.698
Total cholesterol (mg/dl)177 (153–201)178 (153–203)175 (162–198)170 (158–180)0.435
HDL-cholesterol (mg/dl)58 (46–67)57 (44–65)60 (47–73)68 (60–78)0.019
LDL-cholesterol (mg/dl)100 (74–125)99 (73–128)102 (76–121)81 (70–87)0.074
Triglycerides (mg/dl)75 (60–87)72 (59–84)84 (63–88)99 (78–110)0.030
Matsuda index5.5 (3.4–8.8)5.1 (3.6-7.1)6.2 (3.0–11.0)8.9 (5.5–13.3)0.004
HOMA-IR1.6 (1.0–2.4)1.6 (1.1-2.4)1.7 (0.8–2.4)0.9 (0.5–1.7)0.024
Insulinogenic index1.1 (0.6–2.0)1.1 (0.6–2.2)1.1 (0.7–1.6)0.9 (0.6–1.3)0.582
Disposition index (IGIISI)5.4 (3.2–9.0)5.3 (3.2–9.8)5.7 (2.9–8.8)6.4 (4.7–11.5)0.278
OGIS494 (446–542)481 (449–542)503 (417–544)537 (499–549)0.179
MYCL (%)0.48 (0.27–1.07)0.49 (0.28–1.36)0.47 (0.22–0.87)0.50 (0.23–0.75)0.801
PERI (cm2)11.22 (7.91–16.61)11.65 (7.60–17.34)10.67 (8.05–16.20)8.52 (7.07–12.04)0.231

PCOS total: sum of PCOS-NIH and PCOS-ROT; PCOS-NIH: women with PCOS defined according to the criteria of the National Institute of Health; PCOS-ROT: women with PCOS defined according to the Rotterdam criteria; BMI: body mass index: waist: waist circumference; RRsys: systolic blood pressure; RRdia: diastolic blood pressure; HF: heart frequency; HDL-cholesterol: high-density lipoprotein cholesterol; LDL-cholesterol: low-density lipoprotein cholesterol; MYCL: intramyocardial fat; PERI: pericardial fat. Versus controls: ; PCOS-NIH versus PCOS-ROT: .